How will you use tocilizumab in the treatment algorithm for SSc-ILD, given its recent FDA approval?  

I am excited that we finally have evidence for an effective therapy to treat SSc- ILD. Scleroderma is among the most challenging diseases facing the rheumatologist and over the years we have failed in our efforts to identify potentially effective treatment options for patients, especially those with...